Welcome to Placenta•Cord Banking

The most exciting breakthrough in stem cell collection and storage since cord blood banking has arrived! It’s called Placenta•Cord banking, and it’s a way to get more out of stem cell collection and storage. And, it’s available only from LifebankUSA™.

What Is Placenta•Cord Banking?

The most recent breakthrough in stem cell banking, Placenta•Cord banking collects and stores cells from two sources–the placenta and the umbilical cord. Traditional cord blood banking includes only stem cells from the blood drained from the umbilical cord. LifebankUSA’s patented process recovers stem cells from the placenta in addition to those collected through conventional cord blood collection procedures, so you get more stem cells to save for the future. The cells are processed in our state-of-the-art Placenta•Cord laboratories and cryogenically stored (frozen) for your family’s personal use.

Why Bank Placental Stem Cells in Addition to Cord Blood?

To bank the most cells possible. Increasing the total number of cells improves the potential for successful engraftment should your family ever need to use the stem cells you are storing. By banking both placental and cord blood stem cells, you are significantly increasing the number of stem cells stored– and helping to best prepare and protect your family for the future.

Placenta–derived stem cells are intended for autologous and allogeneic use in a first– or second-degree blood relative. Placenta–derived stem cell infusions are performed to provide hematopoietic progenitor cells for hematopoietic reconstitution.

The Promise of Placenta•Cord Banking

1. On average, Placenta•Cord banking collects and stores twice as many CD34+ stem cells. These stem cells play an important role in the speed and probability of the stem cells engrafting upon transplant.
2. Preclinical studies conducted by the Fred Hutchinson Cancer Research Center, a leading cancer research institution, indicate that adding placental stem cells to cord blood stem cells enhances engraftment after transplant.
3. LifebankUSA has been granted approval from the Food and Drug Administration (FDA) to begin a new clinical trial based on administering this combination of placental and cord blood stem cells.

Changing the Future of Stem Cell Banking

LifebankUSA is excited to offer you Placenta•Cord banking with the world’s first placenta-derived stem cell capabilities. And, it is available today! To learn more, call us at 1-877-LIFEBANKUSA (1-877-543-3226).

The chance that a child will use his/her own stored cord blood stem cells during his/her lifetime is estimated at 1 in 400 (J.J. Nietfeld and F. Verter). These odds may increase if there is a family history of certain blood disorders or cancers. The potential risks and benefits of stem cell transplantation vary and depend on many factors, such as the amount and quality of the cord blood stem cells collected, the HLA compatibility between recipient and donor, and the client’s overall health.